FATROX
FATROX
Authorised
- Rifaximin
Product identification
Medicine name:
FATROX
Active substance:
- Rifaximin
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Rifaximin100.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Milk0dayzéro jour après le vêlage si la période de tarissement est égale ou supérieure à 35 jours.
-
Meat and offal0dayEn l’absence de LMR, ne pas consommer la mamelle.
-
Milk35day35 jours après le traitement si la période de tarissement est inférieure à 35 jours.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51XX01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1752658 8/1995
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
